Prasad Roshan, Shukla Samarth, Acharya Sourya, Mittal Gaurav, Wanjari Mayur
Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi (M), Wardha, Maharashtra, India.
Department of Pathology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi (M), Wardha, Maharashtra, India.
Narra J. 2025 Apr;5(1):e1088. doi: 10.52225/narra.v5i1.1088. Epub 2025 Jan 8.
Bone primary malignant giant cell tumor (PMGCT) cases are extremely rare, and the optimal management remains unclear. This case report details the diagnosis and successful management of PMGCT in a 45-year-old female presenting with left knee pain, swelling, and restricted movement for one year. Accompanying weight loss and loss of appetite led the patient to seek tertiary care after unsuccessful prior treatment. Imaging, including X-ray and magnetic resonance imaging (MRI), revealed a tumor measuring 7.9 × 7.7 × 6.6 cm, and histopathological examination using fine needle aspiration cytology confirmed the diagnosis of PMGCT. A multidisciplinary approach was taken, involving orthopedic surgery to remove the tumor successfully, and physiotherapy for postoperative care. The patient underwent tumor excision and curettage under spinal and epidural anesthesia, followed by a week of bed rest, and then physiotherapy was started to aid in limb mobilization. Postoperative care involved blood transfusions, femoral artery stenting, continued physiotherapy and adjuvant radiotherapy, initiated two weeks post-surgery, with a total dose of 50 Gy delivered in 25 sessions to reduce the risk of recurrence. Initial monthly follow-ups, later transitioning to quarterly, showed improved joint mobility and function, with no recurrence at the 9-month follow-up. This case highlights the importance of early diagnosis and a multidisciplinary approach to managing PMGCT. Collaboration across specialties contributed to the positive outcome, even in a resource- limited setting. Long-term monitoring remains essential to detect recurrence, and further research is needed to refine treatment strategies for malignant GCTs.
骨原发性恶性巨细胞瘤(PMGCT)病例极为罕见,最佳治疗方案仍不明确。本病例报告详细介绍了一名45岁女性PMGCT的诊断及成功治疗过程,该患者因左膝疼痛、肿胀及活动受限一年前来就诊。此前治疗失败后,伴随的体重减轻和食欲不振促使患者寻求三级医疗服务。包括X线和磁共振成像(MRI)在内的影像学检查显示一个大小为7.9×7.7×6.6 cm的肿瘤,细针穿刺细胞学检查的组织病理学结果确诊为PMGCT。采取了多学科方法,包括成功切除肿瘤的骨科手术及术后物理治疗。患者在脊髓和硬膜外麻醉下接受肿瘤切除及刮除术,随后卧床休息一周,之后开始物理治疗以帮助肢体活动。术后护理包括输血、股动脉支架置入、持续物理治疗及辅助放疗,放疗在术后两周开始,共25次,总剂量50 Gy,以降低复发风险。最初每月随访,之后改为每季度随访,结果显示关节活动度和功能有所改善,9个月随访时无复发。本病例突出了早期诊断及多学科方法治疗PMGCT的重要性。即使在资源有限的情况下,各专科间的协作也促成了良好的治疗结果。长期监测对于发现复发仍然至关重要,还需要进一步研究以完善恶性GCT的治疗策略。